Wang Kai, Lai Weiwen, Min Tianqi, Wei Jintao, Bai Yan, Cao Hua, Guo Jiao, Su Zhengquan
Guangdong Provincial University Engineering Technology Research Center of Natural Products and Drugs, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Int J Mol Sci. 2024 Apr 13;25(8):4305. doi: 10.3390/ijms25084305.
Endotoxin is a general term for toxic substances in Gram-negative bacteria, whose damaging effects are mainly derived from the lipopolysaccharides (LPS) in the cell walls of Gram-negative bacteria, and is a strong pyrogen. Obesity is a chronic, low-grade inflammatory condition, and LPS are thought to trigger and exacerbate it. The gut flora is the largest source of LPS in the body, and it is increasingly believed that altered intestinal microorganisms can play an essential role in the pathology of different diseases. Today, the complex axis linking gut flora to inflammatory states and adiposity has not been well elucidated. This review summarises the evidence for an interconnection between LPS, obesity, and gut flora, further expanding our understanding of LPS as a mediator of low-grade inflammatory disease and contributing to lessening the effects of obesity and related metabolic disorders. As well as providing targets associated with LPS, obesity, and gut flora, it is hoped that interventions that combine targets with gut flora address the individual differences in gut flora treatment.
内毒素是革兰氏阴性菌中有毒物质的统称,其破坏作用主要源于革兰氏阴性菌细胞壁中的脂多糖(LPS),是一种强烈的致热原。肥胖是一种慢性低度炎症状态,LPS被认为会引发并加剧肥胖。肠道菌群是体内LPS的最大来源,人们越来越认为肠道微生物的改变在不同疾病的病理过程中起着至关重要的作用。如今,连接肠道菌群与炎症状态及肥胖的复杂轴尚未得到充分阐明。本综述总结了LPS、肥胖和肠道菌群之间相互联系的证据,进一步扩展了我们对LPS作为低度炎症疾病介质的理解,并有助于减轻肥胖及相关代谢紊乱的影响。除了提供与LPS、肥胖和肠道菌群相关的靶点外,希望将靶点与肠道菌群相结合的干预措施能够解决肠道菌群治疗中的个体差异问题。